Studies in NSCLC have demonstrated that isoflurane concentrations of 1–3% enhance both cancer cell proliferation and invasion [78], although other studies suggest that sevoflurane may inhibit invasion by downregulating MMPs and HIF-1α [81,82,83]. The gene discussed is HIF1A; the disease is cancer.